Results
eNauka >
Rezultati >
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
| Naziv: | Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study | Autori: | Smolen, Josef S; Pangan, Aileen L; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Juan Ignacio; Zhang, Ying; Damjanov, Nemanja  ; Friedman, Alan; Othman, Ahmed A; |
Godina: | 2019 | Publikacija: | The Lancet | ISSN: | 0140-6736 Lancet Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 393 br. 10188 str. 2303-2311 | DOI: | 10.1016/s0140-6736(19)30419-2 | WoS-ID: | 000470263400027 | Scopus-ID: | 2-s2.0-85066764280 | URI: | https://enauka.gov.rs/handle/123456789/369569 | Izvor metapodataka: | Migrirano iz RIS podataka | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.